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Abstract
Background: Exposure to particulate matter (PM) has been associated with an increase in many inflammatory markers,
including interleukin 6 (IL6). Air pollution exposure has also been suggested to induce an imbalance in the autonomic
nervous system (ANS), such as a decrease in heart rate variability (HRV). In this study we aimed to investigate the modifying
effect of polymorphisms in a major proinflammatory marker gene, interleukin 6 (IL6), on the relationship between long-term
exposure to traffic-related PM10 (TPM10) and HRV.
Methods: For this cross-sectional study we analysed 1552 participants of the SAPALDIA cohort aged 50 years and older.
Included were persons with valid genotype data, who underwent ambulatory 24-hr electrocardiogram monitoring, and
reported on medical history and lifestyle. Main effects of annual average TPM10 and IL6 gene variants (rs1800795; rs2069827;
rs2069840; rs10242595) on HRV indices and their interaction with average annual exposure to TPM10 were tested, applying a
multivariable mixed linear model.
Results: No overall association of TPM10 on HRV was found. Carriers of two proinflammatory G-alleles of the functional IL6 -
174 G/C (rs1800795) polymorphism exhibited lower HRV. An inverse association between a 1 mg/m3 increment in yearly
averaged TPM10 and HRV was restricted to GG genotypes at this locus with a standard deviation of normal-to-normal
intervals (SDNN) (GG-carriers: 21.8%; 95% confidence interval 23.5 to 0.01; pinteraction(additive) = 0.028); and low frequency
power (LF) (GG-carriers: 25.7%; 95%CI: 210.4 to 20.8; pinteraction(dominant) = 0.049).
Conclusions: Our results are consistent with the hypothesis that traffic-related air pollution decreases heart rate variability
through inflammatory mechanisms.
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Introduction
Exposure to air pollution as well as decreased heart rate
variability (HRV) as measured by specific indices (SDNN, TP, LF,
HF) have been associated with increased cardiovascular morbidity
and mortality in longitudinal studies, both in patients with
myocardial infarction and in healthy persons [1–3]. Heart rate
variability (HRV) refers to the beat-to-beat variation in heart rate
and is a non-invasive measure of the autonomic regulation of
cardiac rhythm [4,5]. A reduction in different HRV indices can
reflect both an increase in sympathetic or a decrease in
parasympathetic tone [2]. Several studies have introduced HRV
as an intermediate factor between acute exposure to air pollution
and cardiovascular morbidity, showing that PM exposure is
associated with increased heart rate and reductions in most indices
of HRV [6,7]. A recent meta-analysis including 29 studies
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supported an inverse relationship between HRV and short-term
particulate air pollution [8]. Most studies, including a recent
double-blind randomized cross-over study, often focused on acute
exposure effects and persons with pre-existing cardiovascular
diseases, diabetes mellitus or the elderly [2,9]. Studies on the
chronic impact of air pollution on HRV are scarce [10,11]. The
American Heart Association (AHA) recently stated that studies on
long-term effects of air pollution on HRV and cardiovascular
health are a major unresolved issue. In a previous study analysing
the same study population for the association between long-term
TPM10 and HRV, we found an impact of air pollution on
participants treated for hypertension and heart disease [2].
Air pollution exposure is associated in the short-term with
elevated levels of inflammatory markers such as high-sensitivity C-
reactive protein (hs-CRP), interleukin 6 (IL-6), fibrinogen and
platelet activation, especially in elderly and diabetic subjects, but
also in healthy populations [12–15]. Long-term circulating
interleukin 6 levels in prospectively collected blood are predictive
of subsequent risk of coronary heart disease, making IL6 a strong
candidate gene for modifying air pollution effects on coronary
heart disease related phenotypes including mortality [16–18].
To date, no study has investigated the main association of IL6
polymorphisms on HRV and their modifying effect on the air
pollution-HRV association in the general population. Investigating
the modifying effect of genetic variants in interleukin 6 (IL6)
encoding, a key marker of inflammatory response, on the
association between traffic-related air pollution and heart rate
variability, can improve the understanding of the mediating role of
inflammatory processes. Using data from the ‘‘Swiss cohort study
on air pollution and lung and heart disease in Adults’’
(SAPALDIA) we found novel evidence that genetic variation in
the pleiotropic IL6 gene alters heart rate variability and its
association with long-term exposure to traffic-related particulate
air pollution (TPM10).
Methods
Ethics statement
The study complies with the declaration of Helsinki and ethical
approval for the SAPALDIA study was given by the Swiss
Academy of Medical Sciences, the national ethics committee for
clinical research (UREK, Project Approval Number 123/00) and
the Cantonal Ethics Committees for each of the eight examination
areas (Ethics commissions of the cantons Aargau, Basel, Geneva,
Grisons, Ticino, Valais, Vaud and Zurich). Participants were
required to give written consent before any part of the health
examination was conducted either globally (for all health
examinations) or separately for each investigation.
Study population
This study is part of the SAPALDIA cohort which was designed
to investigate the long-term health effects of air pollution [19,20].
In 1991 a random population sample of white adults aged 18–60
years was recruited from eight areas in Switzerland featuring
distinct geographic and environmental conditions. While the
baseline examination of 9651 persons focused on respiratory
health, at follow-up in 2002 (SAPALDIA2) a random sample of in
total 1846 persons aged $50 years was invited to undergo a 24-hr
electrocardiogram (ECG) recording to assess HRV. Exclusion
criteria were general or spinal anaesthesia within 8 days (n=5),
myocardial infarction within 3 months before the examination
(n=2), taking digitalis (n=6), an artificial internal pacemaker
(n = 0), and ECG recordings showing atrial fibrillation (n=12), less
than 18 hours of recording (n=73) [21] or of insufficient quality
(n=6) [22]. From the 1742 participants with 24-hr ECG
recordings, we finally included 1552 participants with valid data
on cardiovascular risk factors, and TPM10 long-term exposure.
HRV measurements and definition
Measurement of HRV and assessment of cardiovascular risk
factors in SAPALDIA have been previously described [22]
(Methods S1 in File S1). In brief, participants were asked to
follow their regular daily routine during the recording period.
Digital devices with a frequency response of 0.05–40 Hz and a
resolution of 128 samples/s, recording on three leads (V1, altered
V3 with the electrode on the left mid clavicular line on the lowest
rib, and altered V5 with the electrode on the left anterior axillary
line on the lowest rib) were used. The mean duration of the 24-hr
ECG recordings was 22.1 (SD 2.3) hours. The standard deviation
of all normal RR (NN) intervals (SDNN) and the following
frequency domain variables were calculated: total power (TP) (#
0.40 Hz), ultra-low frequency (ULF) power (#0.0033 Hz), very
low frequency (VLF) power (0.0033–0.04 Hz), low frequency (LF)
power (0.04–0.15 Hz), high frequency (HF) power (0.15–0.40 Hz),
and the ratio between LF and HF (LF/HF).
Air pollutant exposure estimation
To assess the effect of long-term exposure to traffic-related
pollution on HRV, exposure was defined as the average
concentration of traffic-related PM10 (TPM10) over 10 years.
Given that total PM10 is not specific to near-road traffic-related
pollutants, we focused instead on TPM10 to capture the high
spatial variability of those source specific pollutants (Methods S1 in
File S1). The dispersion modeling approach is described elsewhere
[23]. In brief, these Gaussian plume models used the traffic-
specific PM10 on-road emissions from light- and heavy- duty
vehicles, buses, and motorcycles, taking into account diurnal
variability, weekday-weekend differences as well as seasonal
patterns. Co-variables used in the dispersion models were wind
speed and direction, temperature, mixing height, and atmospheric
stability classes. By linking participants residential addresses to
annual mean TPM10 exposure concentrations derived for
2006200 meter grid cells from dispersion models and historical
trend data of central site measurements, exposure was individually
assigned to all residences of the participants reported for the period
between 1990 and 2000 [24]. The PM10 exposure modeling and
details of the individual exposure assignment have been described
before [23,24]. Since information on short-term TPM10 was not
available, short-term PM10 exposure was used to assess short-term
effects on HRV in a sensitivity analysis approach. Short-term
PM10 was assessed using averaged fixed monitoring station
pollution measurements of the same day or up to one week
preceding the Holter recording. Data was included from
measurement stations nearest to the subjects’ home addresses.
Subjects living farther than 5 km from a station or having moved
within the previous year were excluded for this sensitivity analysis.
Selection of IL6 genetic variants and genotyping
The single functional nucleotide polymorphism (SNP) in the
IL6 gene locus (rs1800795; IL6 –174 G/C) was selected as the
main candidate to capture the common genetic variation in this
chromosomal region. This SNP has shown to be associated with
circulating IL-6 blood concentrations [25,26]. The G allele was
identified as the proinflammatory allele in previous epidemiolog-
ical and experimental studies. In an explorative supplementary
analysis benefitting from available GWAS data, three additional
IL6-SNPs (rs2069827, rs2069840, rs10242595) were included as
their genotyping call rates were $97.5% and they were haplotype
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tagging SNPs or associated with cardiovascular phenotypes or in
high linkage disequilibrium (LD) with such SNPs (Tables S1–S2 in
File S1).
Genomic DNA was isolated from EDTA-buffered whole blood
using PUREGENETM DNA Purification Kit (GENTRA Sys-
tems, Minneapolis, USA) [19]. Genotypes of three SNPs
(rs2069827, rs2069840, rs10242595) were assessed using the
Sequenom’s MassARRAY system (Sequenom, San Diego, USA)
by performing iPLEX single base primer extension and matrix-
assisted laser desorption ionization time-of-flight mass spectrom-
etry as described elsewhere [27]. Genotypes of one SNP
(rs1800795) were assessed using 5’-nuclease fluorescent realtime
PCR (TaqMan) genotyping assay (Applera Europe, Rotkreuz,
Switzerland). End-point detection was done using a 7000 ABI
System detection device (ABI, Rotkreuz, Switzerland) [28]. For
genotyping quality-control, a random selection of .5% of the
samples were genotyped twice.
Statistical analysis
Hardy-Weinberg equilibrium (HWE) was assessed, irrespective
of HRV measurement, for the total genotyped SAPALDIA
population of 6055 subjects by using the STATA (Table S1 in
File S1) genhwi command for global k-statistic testing. Haploview
4.2 was used for analysis of Lewtonin’s linkage disequilibrium (LD)
calculating the metrics D-prime and R-squared (Table S2 in File
S1).
The SAPALDIA subpopulation for this study is consistent with
our previous analyses on the association between TPM10 and the
log-transformed outcome variable (HRV) [10]. An effect estimate
represents percent change in geometric mean. Covariates included
in the analysis were chosen in accordance with previous analysis
[10] and supplemented by alcohol consumption, passive smoking,
diabetes and noise exposure. Covariates included in the regression
model were: sex (male as reference), age (years), age2, body mass
index (bmi, kg/m2), bmi2, smoking status (never as reference,
ever), daily exposure to environmental tobacco smoke (ETS, none
as reference,,3 hours,.3 hours), daily alcohol consumption (,1
drink as reference, $1 drink), weekly physical activity (to the point
of getting out of breath or sweating) (none as reference, betweenK
and 2 hours, .2 hours), uric acid concentration (micromol/L),
hypertension (no as reference, yes), heart disease (no as reference,
yes), diabetes (no as reference, yes), street and railway noise
exposure (mean dB(A) per night), seasonal effects (sine and cosine
functions of the day of examination with a period of 1 year). High
sensitive C-reactive protein (mg/l) was additionally included in the
model to guard against potential confounding by unmeasured
proinflammatory short-term effects, such as acute air pollution
effects. A random intercept in a mixed regression model was
included to adjust for potential residual clustering of data within
the eight areas of Switzerland.
The underlying genetic model of the SNP effect was defined,
using additive and dominance contrasts in the regression models
and applying the Cochran-Armitage test to assess potential
deviation from the additive model (Methods S1 in File S1). In
such a model a significant dominance contrast measure represents
deviation from the additive allele effect. To further differentiate in
between a dominant and a recessive effect, we considered the
direction of the association of the dominance parameter. In the
paper we only show p-values of the most likely inheritance mode
(additive, dominant or recessive) of the tested main effects of the
IL6 polymorphisms, as well as the interactions of the IL6
polymorphisms with TPM10.
Main effects of IL6 gene variants were derived from the mixed
model described above and adjusted for long-term TPM10. IL6
variants and interaction terms between TPM10 and the IL6
variants were entered into the regression model separately for each
genotype. Genotype-specific effect estimates for TPM10 were
obtained by including the stratum-specific product terms of the
genotype with TPM10 exposure in covariate-adjusted mixed linear
models.
In sensitivity analysis, to control the possible acute effects of
ambient air pollution on HRV, we also adjusted the core mixed
model for the community average ambient PM10-level of the 3
days prior to the Holter recording. Furthermore, we replaced
TPM10 exposure with the annual NO2 exposure averaged over the
previous 10 years. In a previous publication we had not found a
main effect of NO2 on HRV [11].
As this is an exploratory study investigating potential inflam-
matory mechanisms through a genetic key marker of inflammatory
response and a functional SNP in this gene, selected a priori, we
did not adjust for multiple testing [29].
All tests were two-sided with a significance level of 0.05.
Statistical analyses were performed using STATA, version 12
(StataCorp. 2011. Stata Statistical Software: Release 12. College
Station, TX: StataCorp LP) and SAS V 9.2 (SAS Institute, Cary,
NC, 2008).
Results
As described in Table 1, the mean age of the study population
was 60.3 (SD 6.2) years with a mean BMI of 26.7 kg/m2. Among
the subjects, 50.4% were females, 57% ever smokers, 21.5% were
exposed to second hand smoke, 46.3% consumed alcohol
regularly, 41.2% were physically inactive, 47.7% reported
hypertension, 9.5% diabetes and 24.7% a heart disease.
The overall analysis including the whole study population
(n= 1552) showed no general association of any HRV parameter
with TPM10 except for the LF/HF ratio which was 3.6% lowered
(95% confidence interval (95%CI), 26.9 to 20.2) [10]. The
functional IL6-174 G/C (rs1800795; n= 1549) polymorphism,
which was previously associated with circulating IL-6 [30,31], was
associated with some of the HRV metrics in either an additive or a
dominant manner (Table 2). Compared with 2174 GG geno-
types, participants having only one or no G-risk allele exhibited
higher SDNN (GC: 3.8%; 0.8 to 6.8; CC: 4.0%; 95%CI, 0.1 to
8.0; padditive = 0.015) and TP (GC: 7.5%; 95%CI, 0.7 to 14.9; CC:
7.6%; 95%CI, 21.4 to 17.5; padditive = 0.041), while the LF/HF
ratio decreased (GC: 28.8%; 95%CI, 214.7 to 22.5; CC: 2
1.3%; 95%CI, 29.6 to 8.0; pdominant = 0.021). No significant
overall association was observed for HF and LF power. None of
the other IL6 SNPs included in the supplementary explorative
analysis were statistically significantly associated with HRV
(Tables S3–S7 in File S1).
Table 3 presents the results for the interaction between TPM10
exposure and the IL6-174 G/C on change in HRV. The IL6-174
G/C polymorphism showed interactions with traffic-related PM10
and the following HRV metrics: SDNN (pinteraction(additive) = 0.028)
and LF (pinteraction(dominant) = 0.049) (Table 2). A 1 mg/m
3 incre-
ment in yearly averaged TPM10 level was associated with
a decrease in SDNN of 1.8% (95% confidence interval (95%CI),
23.5 to 0.01) and in LF power of 5.7% (95%CI,210.4 to20.8) in
participants with the 2174 GG genotype. No significant
interaction with TPM10 exposure and the other HRV metrics
(TP, HF power and LF/HF ratio) was observed but for all
parameters except HF, TPM10 decreased heart rate variability
strongest among GG genotype carriers. All other IL6 SNPs
included in the supplementary analysis showed a weaker or no
Does the IL6-174G/C SNP Alter the Heart Response to Air Pollution?
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Table 1. Characteristics of the study population (N= 1552).
Characteristics All (n = 1552)
Gender
Men 770 49.6%
Women 782 50.4%
Age 60.3 66.2
Lifestyle factors
Smoking status
Never Smokers 668 43.0%
Ever Smokers 884 57.0%
ETS exposure
None 1218 78.5%
,3 h/ day 217 14.0%
$3 h/ day 117 7.5%
Alcohol
,1glass / day 834 53.7%
$1glass / day 718 46.3%
Physical acitivity
None 640 41.2%
0.5–1.5 h/ week 508 32.7%
$2 h/ week 404 26.0%
Cardiovascular health
Systolic blood pressure (mmHG) 132.1 619.1
Diastolic blood pressure (mmHG) 81.7 610.5
BMI (kg/m2) 26.7 64.3
Diabetes
No 1404 90.5%
Yes 148 9.5%
Hypertension
No 811 52.3%
Yes 741 47.7%
Heart disease
No 1168 75.3%
Yes 384 24.7%
Noise Exposure
Street noise (dB(A)) 38.3 67.7
Railway noise (dB(A)) 6.0 610.7
Air pollution
Average annual traffic related PM10 (mg/m3)a 2.3 61.3
3-days lag PM10 (mg/m3)b 22.0 614.5
IL6 polymorphisms
candidate SNP: rs1800795 (2174G/C) 1549
GG 584 37.7%
GC 704 45.4%
CC 261 16.8%
SNPs included in exploratory analyses: rs2069827 1524
GG 1264 82.9%
GT 246 16.1%
TT 14 0.9%
rs2069840 1526
CC 638 41.8%
CG 706 46.3%
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effect modification of TPM10 on HRV, respectively, and did not
add additional information (Tables S8–S12 in File S1).
In order to guard against confounding by short-term exposure
of PM10, which was not considered in the main and interaction
effect model, we included a mean daily PM10 exposure measure-
ment over the three days previous to the ECG assessment.
Associations reported for long-term exposure to TPM10 with IL6
polymorphisms and their interactions differed only slightly when
adjusting additionally for short-term PM10 exposure (data not
shown). When we replaced TPM10 with NO2 we observed
interactions with IL6-174 G/C that were highly comparable to
those observed for TPM10 (data not shown).
Discussion
To our knowledge, this is the first report on both, the main
effect of genetic variation in IL6 on HRV and the interaction of
IL6 polymorphisms with air pollution on HRV. In this candidate-
approach association study in the general population, we observed
the previously described functional IL6-174G/C promoter poly-
morphism to be associated with HRV (SDNN; TP; LF; HF). The
association of TPM10 with decreased HRV parameters was
restricted to carriers of the IL6-174 GG genotype. The results
lend support to the notion that inflammatory mechanisms mediate
part of the air pollution related effects on heart rate variability.
The pleiotropic cytokine IL-6 is central in acute and chronic
inflammation by inducing hepatic synthesis of acute phase proteins
and by modulating the inflammatory response. In other studies,
circulating IL-6 as well as hs-CRP were inversely associated with
parasympathetic nervous system tone measured as LF of HRV
both, in healthy individuals and patients with CVD or diabetes
[32,33]. Separate lines of evidence provide support to the role of
genetic variation in IL6 in low grade systemic inflammation and,
albeit less consistently, cardiovascular disease risk. First, several
studies investigated the association of IL6 gene variants with
circulating IL-6 concentrations and with gene activity, most of
them focusing on the SNP IL6-174 G/C (rs1800795) [30,31]. The
IL –174 G-allele, which was associated with lower HRV in this
current study was previously associated with higher IL-6 blood
concentrations, higher IL6 gene transcriptional activity, and
higher inducible IL-6 responses [34,35]. The restriction of the
TPM10 effect on lowering HRV is therefore consistent with an
effect in a subgroup predisposed to a proinflammatory state.
Second, increased serum levels of repeatedly measured IL-6 were
observed among survivors of myocardial infarction who carried
the G-allele of this SNP [31]. Third, IL6 polymorphisms and in
particular the 2174 G/C variant were previously associated with
various cardiovascular disease outcomes and risk factors, including
ischemic cerebrovascular events [36], coronary heart disease
[37,38], high blood pressure [37,39], total cholesterol, LDL,
fasting glucose, BMI [40], carotid artery compliance and carotid
intima media thickness [39,41] as well as arterial stiffness and pulse
pressure [42]. Yet, in a meta-analysis from 2006 [38] the authors
concluded that most of the studies looking at the 174 G/C
promoter polymorphism and its association with risk of coronary
heart disease (CHD) were case-control studies showing heteroge-
neous associations between the genotypes and risk of cardiovas-
cular heart disease. In contrast, we excluded all severely ill patients
to specifically assess potential effects on HRV in the general
population.
Evidence to support the role of systemic low grade inflammation
in mediating susceptibility of the autonomic nervous system to air
pollution is sparse. A small panel study reported short-term effects
of particulate air pollution on decreased HRV to be stronger
among elderly persons with high levels of CRP and fibrinogen
[43]. While studies on the interaction between air pollution and
inflammatory gene variants may be better suited for assessing
susceptibility to long-term exposures, data on gene-air pollution
interactions in cardiovascular health area generally very sparse as
recently reviewed by Zanobetti et al. [44]. In fact, all results
published on gene-air pollution interactions in relation to HRV
were derived from a single study, the Normative Ageing Study of
men, and focused on acute effects of air pollution. Results from
this study generally support the role of pulmonary or systemic
oxidative stress in linking air pollution and HRV [45,46]. The
SAPADIA cohort team previously reported on the modifying
effect of antioxidative GST gene polymorphisms (GSTM1 and
GSTT1 gene deletions and the GSTP1 SNP Ile105Val) in the
association of HRV with the inflammatory risk factors second-
hand smoke and obesity in the general population [47]. These
GST polymorphisms did not modify the association between
TPM10 and HRV in this study.
A major strength of our study is the population-based design
and the detailed information available on participants. The
exposure assessment of TPM10 with individual exposure estimates
taking residential history into consideration has advantages to
assess long-term exposure to traffic-related air pollution, providing
good differentiation. Due to the detailed information on numerous
cardiovascular risk factors, we were able to control for major
confounding factors. Furthermore, we were able to guard our
analysis of long-term TM10 effects against confounding by short-
term PM10 exposure. The likely absence of confounding by short-
term air pollution is further supported by the fact that non-
inclusion of high sensitive C-reactive protein as model covariate
did not materially alter the results (Tables S13-S14 in File S1).
This study has also a number of limitations. First, the results
presented refer to statistical associations and interactions. The low
Table 1. Cont.
Characteristics All (n = 1552)
GG 182 11.9%
rs10242595 1529
GG 664 43.4%
GA 686 44.9%
AA 179 11.7%
ETS indicates environmental tobacco smoke exposure; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index;
aAnnual average over 10 years previous to the study.
baverage over 3 days previous to the HRV measurement.
doi:10.1371/journal.pone.0104978.t001
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prevalence of some genotypes limited statistical power of the
explanatory analyses. Calculations indicate we had sufficient
power to observe a main effect and a TPM10 interaction effect
for the candidate SNP IL6-174 G/C on SDNN of the order of
magnitude reported or larger. These power calculations assumed
different HRV parameters to not be independent. Second, we did
not have information about IL-6 serum levels and cannot draw
conclusions on how the polymorphisms studied influenced the
circulating IL-6 levels and finally the cardiovascular health of the
SAPALDIA participants. But the IL6-174 G/C SNP was
associated with higher high sensitive C-reactive protein (mg/l)
concentrations in the blood (GG: 2.8; GC: 2.5; CC: 2.4). Third,
data on short-term TPM10 was not available, and hence short-
term exposure was assessed using averaged normal PM10 from
fixed monitoring station measurements. We had obtained 24-hr
ECG recordings only once for each participant and were therefore
not able to look at longitudinal changes in HRV and its association
with the incidence of cardiovascular diseases. Fourth, we had
previously reported that the association between TPM10 and HRV
is restricted to persons reporting intake of angiotensin converting
enzyme inhibitors (ACEI) [10]. The now reported interaction
between the IL6-174G/C polymorphism and TPM10 remained
unchanged after exclusion of participants on ACEI, but we lacked
the statistical power for formal assessment of 3-way interactions
between TPM10, IL6 variants and ACEI. Finally, we were unable
to adjust our analysis for some short-term factors influencing
HRV, such as physical exercise. However, physical exercise at the
time of heart rate variability measurement is unlikely to be
associated with chronic exposure to TPM10 and thus unlikely to
confound the associations reported.
Conclusions
In summary, this cross-sectional study from the general
population provides supportive evidence that genetic variation in
one of the major proinflammatoy cytokines, IL6, alters HRV and
its association with long-term exposure to traffic-related particulate
air pollution. Our findings contribute to the research effort to
pinpoint biologic mechanisms mediating air pollution related
broad health effects. While the results guide future research efforts
to use IL6 as an important candidate gene in studies of HRV and
air pollution, they essentially need replication in different study
populations, in longitudinal studies, for different air pollution
exposure metrics, and with genetic variant information derived
from deep sequencing of the IL6 gene region.
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Table 3. Adjusteda estimates of the mean percent difference of HRV associated with a 1 mg/m3 increase in average exposure to
traffic-related PM10b by IL6-174 G/C genotypes (N= 1549).
HRV parameters IL6-174 G/C Estimatea 95% CI pTPM10 (by genotype)
c pinteraction (genetic model)
d
SDNN GG 21.77 23.51 0.01 0.051 0.028 (1)
GC 1.06 20.47 2.62 0.177
CC 0.73 21.62 3.14 0.545
Total Power (TP) GG 23.34 27.22 0.71 0.105 0.177 (1)
GC 2.54 21.00 6.20 0.161
CC 21.00 26.22 4.51 0.717
Low Frequency Power (LF) GG 25.70 210.36 0.81 0.023 0.049 (2)
GC 1.51 22.87 6.09 0.506
CC 24.98 211.00 1.45 0.126
High Frequency Power (HF) GG 20.16 26.36 6.45 0.961 0.671 (1)
GC 2.70 22.84 8.55 0.346
CC 23.83 211.53 4.54 0.359
LF/ HF Ratio GG 25.82 29.88 1.57 0.008 0.070 (2)
GC 21.51 25.24 2.37 0.441
CC 21.54 26.98 4.21 0.592
HRV indicates heart rate variability: SDNN indicates standard deviation of all NN intervals (units ms); TP, total power (ms2); HF, high frequency power (ms2); LF, low
frequency power (ms2).
aadjusted for gender, age, age squared, BMI, BMI squared, smoking status, environmental tobacco smoke exposure, alcohol consumption, physical activity, high-
sensitivity C-reactive protein, uric acid levels, hypertension, heart disease, diabetes, street and railway noise, seasonal effects and area.
bAnnual average over 10 years previous to the study.
cp-values for the genotype- specific TPM10 effect estimate.
dp-values of interaction effects of the IL6-174 G/C polymorphism with TPM10 on HRV were tested for additive, dominant and recessive genetic models; p-values of the
most significant mode of inheritance are presented (additive1 or dominant2).
doi:10.1371/journal.pone.0104978.t003
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